Nationwide Fund Advisors - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 43 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2017$1,150,000
-49.6%
22,952
-53.4%
0.01%
-44.4%
Q2 2017$2,282,000
+64.5%
49,299
+25.5%
0.01%
+50.0%
Q1 2017$1,387,000
+189.0%
39,286
+2.4%
0.01%
+200.0%
Q4 2016$480,000
-12.6%
38,365
-3.3%
0.00%0.0%
Q3 2016$549,000
+55.1%
39,665
+10.6%
0.00%0.0%
Q2 2016$354,000
+18.0%
35,864
+101.9%
0.00%
+100.0%
Q1 2016$300,000
-24.1%
17,7640.0%0.00%
-50.0%
Q4 2015$395,000
+45.2%
17,764
+54.3%
0.00%
+100.0%
Q3 2015$272,000
-60.9%
11,513
+35.2%
0.00%
-66.7%
Q2 2015$696,000
+61.1%
8,513
+82.6%
0.00%
+50.0%
Q1 2015$432,000
+136.1%
4,661
+2.9%
0.00%
+100.0%
Q4 2014$183,000
+112.8%
4,530
+29.5%
0.00%
Q3 2014$86,000
+56.4%
3,4980.0%0.00%
Q2 2014$55,0000.0%3,498
-3.8%
0.00%
Q1 2014$55,000
+10.0%
3,6350.0%0.00%
Q4 2013$50,000
+108.3%
3,635
+185.1%
0.00%
Q3 2013$24,0001,2750.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2014
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$27,840,84218.82%
Ikarian Capital, LLC 1,891,147$11,781,8462.84%
Altium Capital Management LP 620,000$3,862,6001.96%
Ikarian Capital, LLC 1,296,900$8,079,6871.95%
Parkman Healthcare Partners LLC 822,784$5,125,9441.36%
Deep Track Capital, LP 4,000,000$24,920,0001.05%
Monaco Asset Management SAM 470,100$2,928,7230.88%
BRAIDWELL LP 3,393,405$21,140,9130.71%
Telemetry Investments, L.L.C. 71,000$4420.70%
Rhenman & Partners Asset Management AB 900,000$5,607,0000.58%
View complete list of ESPERION THERAPEUTICS INC NE shareholders